221 CRESCENT STREET, WALTHAM, MA
Market cap: $48.6M (11/26/2023)
Price: $12.01
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Spyre Therapeutics Enters Underwriting Agreement for $275 Million Offering
Spyre Therapeutics Reports Preliminary Cash Position of $486.2 Million
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Investor Presentation
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Corporate Update
Annual Report to Security Holders
Q3
Q2
Q1
Amended Quarterly Report
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement